194TiP: LUNAR: Phase III Study of Front-Line Chemotherapy With TTFields for Advanced Squamous NSCLC

Journal of Thoracic Oncology- United States

doi 10.1016/s1556-0864(16)30303-3

Full Text

Abstract

Available in

Categories

Respiratory Medicine

Date

April 1, 2016

Authors

Publisher

Elsevier BV

Related search

Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

Anticancer Research

Cancer Research

English

MA12.06 STELLAR – Final Results of a Phase 2 Trial of TTFields With Chemotherapy for First-Line Treatment of Malignant Pleural Mesothelioma

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.17-27 IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC With Atezolizumab + Chemotherapy

Journal of Thoracic Oncology

Respiratory Medicine

English

Pcn34 - Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-Squamous NSCLC – A Network Meta-Analysis

Value in Health

Occupational Health

English

157P Second-Line Afatinib for Patients With Locally Advanced or Metastatic NSCLC Harbouring Common EGFR Mutations: A Phase IV Study

Journal of Thoracic Oncology

Respiratory Medicine

English

Mitomycin C and Vinorelbine for Second-Line Chemotherapy in NSCLC – A Phase II Trial

British Journal of Cancer

Cancer Research

English

Afatinib in Locally Advanced/Metastatic NSCLC Harboring Common EGFR Mutations, After Chemotherapy: A Phase IV Study

Lung Cancer Management

English

EGFR Molecular Profiling in Advanced NSCLC: A Prospective Phase II Study in Molecularly/Clinically Selected Patients Pretreated With Chemotherapy

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.04-25 EMPOWER-Lung 3: A Phase 3 Study of Cemiplimab, Ipilimumab and Chemotherapy in Advanced NSCLC With PD-L1 <50%

Journal of Thoracic Oncology

Respiratory Medicine

English